Evidence map›Paper›PMID 41346873›Full record

ArticleCureus2025

Overlapping Pathways: Autism Spectrum Disorder in Fragile X Carrier States and the Need for Greater Awareness.

Maria V Fernandez, Alexandra Sirven, Brooke Pickles, Sheena Hamid, Aimee Nunez Selva

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria V FernandezPediatric Medicine, Florida International University, Miami, USA.
Alexandra SirvenPediatric Medicine, American University of Antigua College of Medicine, St. John's, ATG.
Brooke PicklesPediatric Medicine, American University of Antigua College of Medicine, St. John's, ATG.
Sheena HamidPediatric Medicine, American University of Antigua College of Medicine, St. John's, ATG.
Aimee Nunez SelvaPediatric Medicine, American University of Antigua College of Medicine, St. John's, ATG.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fragile X syndrome (FXS), caused by a full mutation (>200 CGG repeats) in the gene Fragile X messenger ribonucleoprotein 1 (FMR1), is the most common single-gene cause of autism spectrum disorder (ASD). Far less is known about the clinical significance of smaller FMR1 expansions. In this case series, we describe four male patients with ASD who carried the FMR1 intermediate (gray-zone) alleles (45-50 CGG; counts: 45, 49, 49, 50). All had early speech/language delay with ASD-consistent features (social-communication deficits, sensory sensitivities, and repetitive behaviors). Common comorbidities included attention-deficit/hyperactivity disorder (ADHD) features and sleep disturbance responsive to standard interventions. None of them met premutation (55-200 CGG) or full-mutation criteria. These observations align with emerging evidence that gray-zone alleles can be associated with neurodevelopmental phenotypes, including ASD traits, in a subset of carriers. Clinically, the series reinforces guidance to include FMR1 analysis in genetic evaluations for unexplained developmental delay/ASD and to provide counseling when intermediate results are identified. Awareness of a potential overlap between the FMR1 gray-zone states and ASD may aid comprehensive evaluation and family counseling. Larger, controlled studies, especially those incorporating AGG interruption analysis, are needed to quantify risk and clarify mechanisms underlying phenotypic variability.

Indexed as

autism spectrum disorder (asd)cgg repeatsfmr1fragile x syndrome (fxs)fxandgray zoneintermediate alleleneurodevelopmental disorderpremutation

Identifiers

PMID41346873
PMCPMC12672945

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.